Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression
ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma
Aragen launches India’s first women-led chemistry synthesis laboratory
Vaccine strategy induces broadly neutralising HIV antibodies
Osaka looks to become global life sciences hub
Positive data moving breast cancer trial forward
Engineering dendritic cells boosts cancer immunotherapy
Ambros Therapeutics launches with $125m to take on complex regional pain syndrome type 1
ADEL and Sanofi sign $1.04bn licence agreement for Alzheimer’s therapy
Aukera Therapeutics emerges from stealth
FDA clears allogeneic CAR-T recurrent glioblastoma therapy for phase II trial
Platform to test new cancer treatments